Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New CT scan could replace multiple heart tests after attack

NCT ID NCT02360150

Diagnosis Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a special CT scan can accurately assess heart muscle damage in people who had a heart attack more than 24 hours earlier. The goal was to see if this CT could replace the need for both an MRI and an invasive angiogram. The study enrolled 31 adults and compared the CT results to those from a cardiac MRI. The trial was terminated early, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dual-energy cardiac CT scan
What this could lead to
If successful, this could show that a single CT scan can replace multiple tests, making heart damage assessment faster and safer for patients.
What could go wrong
This was a small, early study that was terminated early, so results are limited. The CT scan also involves radiation, which carries a small long-term risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

31 people

The number who actually took part.

Started

Jan 2015

Finished

Oct 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Man or woman * Major patient * Patient with electrical, biological and clinical signs of myocardial infarction, with late presentation (\>24 hours) * Creatinine clearance (calculated using the Cockcroft (\<age 65) or MDRD (\> 65 years))formula \> 30 ml / min. * Affiliation to the french social security scheme. * Women of childbearing age: Negative pregnancy test (urine test). * Postmenopausal women, menopause confirmation of diagnosis * Patient able to understand the spoken and written French. * Signature of informed consent Exclusion Criteria: * Collapsus or organ failure requiring urgent care in intensive care unit * Arrhythmia and/or non-reducible tachycardia. * History of allergic reaction after iodinated contrast medium injection. * History of nephrogenic systemic fibrosis. * History of claustrophobia * Unbalanced asthma. * Acute pulmonary edema. * Pregnant or breastfeeding women. * Clinical signs of thyrotoxicosis. * Person placed under judicial protection, * Patient suffering from serious psychiatric disease. * Patients participating in another clinical trial. * Contraindication to MRI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction

Contacts and locations

Locations

  • University Hospital of Rouen

    Rouen, Normandy, 76031, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.